Platform Growth Oxurion is actively expanding through a buy-and-build strategy to consolidate CRO and clinical data capabilities across Europe, presenting multiple cross-sell opportunities into its growing network of 20+ partners and potential access points to Axiodis’ Exagis platform.

AI and eClinical The company is building an AI-driven, modular eClinical software platform including Exagis with intelligent data validation and virtual patient technologies, creating upsell paths for biotech and pharma sponsors seeking advanced data integrity and efficiency in trials.

Regulatory Readiness Axiodis and Oxurion emphasize regulatory-ready clinical data, biometrics, and data management capabilities, offering sales angles around faster regulatory submissions, compliant data workflows, and reduced audit risk for European sponsors.

Financing Momentum Recent and ongoing financing facilities aimed at digital assets and strategic investments signal strong fundraising support and potential for co-investment or milestone-based partnerships to fund platform expansions and client wins.

Clinical Expertise Network With 7,000+ patient files across 12+ countries and a broad network of 20+ academic, biotech, and pharmaceutical partners, there are strategic opportunities to propose integrated CRO services combined with Exagis data management and statistical analysis to end-to-end trial programs.